Penn Medicine Provider
Medical Oncology
Samuel U. Takvorian, MD, MS
5.0
(533)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location

About me

  • Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Harvard Medical School
  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

533 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
the doctor showed concern.
May 2025
5.0
5.0
on time curtesy and informative
May 2025
5.0
5.0
very supportive
May 2025
5.0
5.0
all was great

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Takvorian is a Penn Medicine physician.

Qualifications and experience

My research

Seiichi Villalona, Carlos Chavez Perez, E. Paul Wileyto, Samuel Takvorian, Peter Gabriel, Abigail Doucette, Daniel Blumenthal, Robert Schnoll Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer , Psycho-Oncology: 2024


Gabriel Aleixo, Tej Patel, Julianne Ani, Will J. Ferrell, Efrat Dotan, Samuel U. Takvorian, Grant R. Williams, Ravi B. Parikh, Ramy Sedhom “Start low, go slow,” a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis , Journal of Geriatric Oncology: 2024


Schnoll R, Bekelman JE, Blumenthal D, Asch DA, Buttenheim AM, Chaiyachati KH, Domchek SM, Fayanju OM, Gabriel P, Jenssen BP, Leone FT, McCarthy AM, Nathanson KL, Parikh RB, Rendle KA, Shelton RC, Shulman LN, Takvorian SU, Ware S, Wileyto EP, & Beidas RS Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control , Journal of Clinical and Translational Science, 8(1): 2024


J. Wainwright, H. Toneff, J. Kalman, M. Mengesha, A. Strazinsky, W. Song, S. Beucker, E.P. Wileyto, C. Johnston, C. Cambareri, D. Yarosh, A. Blauch, D. Pucci, L.A. Jacobs, J.E. Bekelman, S.E. Kimmel, L.N. Shulman, S. Takvorian, K. Rendle Acceptability and Feasibility of Integrating A Chatbot into Routine Lung Cancer Care: Patient and Clinician Perspectives , Journal of Thoracic Oncology, International Association for the Study of Lung Cancer, 19(10): 2024


Montgomery A, White J, Blumenthal D, Mengesha M, O’Brien C, Ragusano D, Beidas RS, Schnoll R, Bekelman JE, Parikh RB, Takvorian SU, & Rendle KA Patient and clinician perspectives on the timing of serious illness conversations in oncology , ASCO Quality Care Symposium, San Francisco, CA: 2024


Miles Hsu, Xinhe Shan, Rebecca Zhang, Eva Berlin, Arun Goel, Manuj Agarwal, Yu-Ning Wong, John P. Christodouleas, David J. Vaughn, Vivek Narayan, Samuel U. Takvorian, Neha Vapiwala, Austin R. Pantel, Naomi B. Haas Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on (18)F-DCFPyL PET/CT , Clinical Genitourinary Cancer, 22(4): 2024


Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer , Eur Urol Oncol: 2024


Erin Welch, Marie A. Guerraty, Biniyam G. Demissei, Naomi Haas, Samuel Takvorian, Ravi B. Parikh, David J. Vaughn, Daniel Pryma, David A. Mankoff, Bonnie Ky, Vivek Narayan Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy , Clinical Genitourinary Cancer, 22(4): 2024


Takvorian SU, Gabriel P, Wileyto EP, Blumenthal D, Tejada S, Clifton ABW, Asch DA, Buttenheim AM, Rendle KA, Shelton RC, Chaiyachati KH, Fayanju OM, Ware S, Schuchter LM, Kumar P, Salam T, Lieberman A, Ragusano D, Bauer AM, Scott CA, Shulman LN, Schnoll R, Beidas RS, Bekelman JE, Parikh RB. Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial , JAMA Network Open: 2024


William L. Schpero (co-first), Samuel U. Takvorian (co-first), Daniel Blickstein, Afrah Shafquat, Jingshu Liu, Arnaub K. Chatterjee, Elizabeth B. Lamont, Paula Chatterjee Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials , Journal of Clinical Oncology: 2024


View all publications